Finance
Results: 85-96 of 32013

Celltrion Presents Positive Real-World Data on Switching from intravenous (IV) to subcutaneous (SC) infliximab at UEG Week 2025 Meet the Expert sessions

COSRX Wraps Up "COSRX Glow Market" Pop-Ups Successfully in Paris & London, Accelerating Its Expansion in Europe
